Lucchinetti, C
Moreover, we excluded patients and controls who suffered from neurodegenerative and neuroinflammatory disorders, such as chronic fatigue syndrome [54], Parkinsons or Alzheimers disease, multiple sclerosis, stroke, or systemic (auto)immune diseases such as diabetes mellitus, psoriasis, rheumatoid arthritis, inflammatory bowel disease and scleroderma, and liver and renal disease
Theres no definitive answer because insurance coverage depends on your specific health plan
The most common side effects of tirzepatide are gastrointestinal, including nausea (12-24%), diarrhea (12-17%), vomiting (6-10%), constipation (6-11%), and decreased appetite
We prioritize personalized care, closely monitoring your progress to avoid unnecessary or excessively frequent treatments, as overuse of IV therapy could potentially lead to fluid and electrolyte imbalances or other complications